Chronic tearing induced by apremilast

Ann Allergy Asthma Immunol. 2018 Sep;121(3):375. doi: 10.1016/j.anai.2018.06.027. Epub 2018 Jun 30.

Authors

Matthew R Norris¹, Leonard Bielory²

Affiliations

¹ Department of Medicine Overlook Medical Center Summit, New Jersey.
² Rutgers University Center for Environmental Prediction New Brunswick, New Jersey. Electronic address: bielory@rutgers.edu.

PMID: 29969663
DOI: 10.1016/j.anai.2018.06.027

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Anti-Inflammatory Agents, Non-Steroidal / adverse effects*
Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
Conjunctivitis / chemically induced*
Cyclic Nucleotide Phosphodiesterases, Type 4 / metabolism
Female
Humans
Lacrimal Apparatus Diseases / chemically induced*
Middle Aged
Phosphodiesterase 4 Inhibitors / adverse effects*
Phosphodiesterase 4 Inhibitors / therapeutic use
Psoriasis / drug therapy
Tears / metabolism
Thalidomide / adverse effects
Thalidomide / analogs & derivatives*
Thalidomide / therapeutic use

Substances

Anti-Inflammatory Agents, Non-Steroidal
Phosphodiesterase 4 Inhibitors
Thalidomide
Cyclic Nucleotide Phosphodiesterases, Type 4
apremilast